Back to search

Article

Adaptation-proof SARS-CoV-2 vaccine design

2022-05-18

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface spike glycoprotein - a major antibody target - is critical for virus entry via engagement of human angiotensin-converting enzyme 2 (ACE2) receptor. Despite successes with existing vaccines and therapies that primarily target the receptor binding domain (RBD) of the spike protein, the susceptibility of RBD to mutations provides escape routes for t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
675f07da-3197-53cc-b653-5146a4ade8ab
DOI
10.1101/2022.05.17.492310
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adaptation-proof SARS-CoV-2 vaccine designDOI 10.1101/2022.05.17.492310
Select a neighboring publication to make it the new centre.